Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort.
Af Björkesten CG, Ilus T, Hallinen T, Soini E, Eberl A, Hakala K, Heikura M, Jussila A, Koskela R, Koskinen I, Moilanen V, Nielsen C, Nieminen U, Nuutinen H, Heikkinen M, Suhonen UM, Tillonen J, Utriainen K, Vihriälä I, Wennerström C, Borsi A, Nissinen R, Koivunen MR, Sipponen T. Af Björkesten CG, et al. Among authors: eberl a. Eur J Gastroenterol Hepatol. 2020 Dec;32(12):1507-1513. doi: 10.1097/MEG.0000000000001831. Eur J Gastroenterol Hepatol. 2020. PMID: 32868649 Free PMC article.
Ustekinumab for Crohn's disease: a nationwide real-life cohort study from Finland (FINUSTE).
Eberl A, Hallinen T, Af Björkesten CG, Heikkinen M, Hirsi E, Kellokumpu M, Koskinen I, Moilanen V, Nielsen C, Nuutinen H, Suhonen UM, Utriainen K, Vihriälä I, Soini E, Wennerström C, Nissinen R, Borsi A, Koivunen M, Tillonen J, Sipponen T. Eberl A, et al. Scand J Gastroenterol. 2019 Jun;54(6):718-725. doi: 10.1080/00365521.2019.1624817. Epub 2019 Jun 11. Scand J Gastroenterol. 2019. PMID: 31184512
A nationwide real-world study on dynamic ustekinumab dosing and concomitant medication use among Crohn's disease patients in Finland.
Sipponen T, Af Björkesten CG, Hallinen T, Ilus T, Soini E, Eberl A, Heikura M, Kellokumpu M, Koskela R, Nielsen C, Nuutinen H, Heikkinen M, Suhonen UM, Tillonen J, Wennerström ECM, Borsi A, Koivunen MR; FINUSTE Study group. Sipponen T, et al. Among authors: eberl a. Scand J Gastroenterol. 2021 Jun;56(6):661-670. doi: 10.1080/00365521.2021.1906315. Epub 2021 Apr 5. Scand J Gastroenterol. 2021. PMID: 33820465 Free article.
[No title available]
[No authors listed] [No authors listed] PMID: 36165077
Real-world assessment of multipolar and point-by-point mapping for premature ventricular contraction ablation.
Sousa PA, Tonko J, Dilling-Boer D, Barra S, Eberl AS, Pezo B, Cortez-Dias N, Khoueiry Z, Medeiros P, Rodríguez-Mañero M, Lebreiro A, Pereira M, Puga L, Scherr D, António N, Ferreira A, Saleiro C, Lagrange P, Adão L, de Sousa J, Elvas L, Oliveira M, Gonçalves L, Silberbauer J. Sousa PA, et al. Among authors: eberl as. Europace. 2024 Jun 3;26(6):euae148. doi: 10.1093/europace/euae148. Europace. 2024. PMID: 38818846 Free PMC article.
Comparing pulsed field electroporation and radiofrequency ablation for the treatment of paroxysmal atrial fibrillation: design and rationale of the BEAT PAROX-AF randomized clinical trial.
Erhard N, Frison E, Asselineau J, Aouar B, Boveda S, Cochet H, Deisenhofer I, Deneke T, Gimbert A, Kautzner J, Knecht S, Maury P, Neuzil P, Rousset M, Scherr D, Schneider CW, Sermesant M, Wichterle D, Jaïs P; BEAT-AF Study group. Erhard N, et al. Europace. 2024 May 2;26(5):euae103. doi: 10.1093/europace/euae103. Europace. 2024. PMID: 38646926 Free PMC article.
37 results